Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 24561
Evènement :Map 2017 : Molecular Analysis For Personalised Therapy

Dates :Vendredi 13 Octobre 2017 - Samedi 14 Octobre 2017

Schulstrasse 44
8050 Zurich, Suisse

Type :Congrès - Audience Internationale

Accréditation :12 crédits



On October 13 – 14 we will be in Zurich, Switzerland to discuss the clinical interpretation of molecular tests for metastatic cancers, alongside medical oncologists, researchers, onco-geneticians, clinical investigators, molecular biologists, cytopathologists, radiotherapists, fellow, academics, regulators and Industry R&D representatives.

Given the rapid increase in targeted therapies now available, we anticipate attendees and speakers at the third MAP Conference will propel ideas and broker new discussions on how to interpret genomic data in precision medicine.

Over two days, world-renowned medical and health professionals will present findings on various topics related to personalised cancer therapy. These discussions are important to help diminish the major gap between our understanding of cancer biology and our evolving approach to patient management.

Topics for this year include:

 • Macroevolution and impact on treatment resistance
 • New models and technologies for personalised medicine
 • Personalised medicine applied to immunotherapeutics
 • Therapeutic targets in cancer
 • Treatment advances in central nervous system tumours
 • Tumour microenvironment and treatment resistance
 • Understanding the broader tumour microenvironment
 • What’s new in the field of clinical trials?

A joint initiative of ESMO, UNICANCER and Cancer Research UK, this conference shines a light on the latest medical developments in a constantly evolving field.


The best abstracts submitted for MAP 2017 will be selected to present their findings during the sessions at the conference.

New to MAP 2017: accepted abstracts will be edited in the "Annals of Oncology" journal.


Accreditation of MAP 2017 will be announced soon.

The MAP 2016 edition was accredited 12 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).







Plan et itinéraire
Adresse du congrès :
Schulstrasse 44
8050 Zurich
Plan et itinéraire


Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama


Map 2017 : Molecular Analysis For Personalised Therapy Oncologie - Cancérologie - Hématologie - Immunologie
cancer research, unicancer, esmo, molecular analysis, personalised therapy, genome, oncology, metastatic
450 30 10


Pour plus d'informations sur Map 2017 : Molecular Analysis For Personalised Therapy, veuillez contacter Overcome

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama

Recommander cet évènement